【Company Research】Kuaishou (1024 HK) – Expecting a solid start in FY22E |
【Company Research】PICC P&C (2328 HK) – Expect CoR improvement in FY22 |
【Company Research】Xpeng Inc. (XPEV US) – Mixed 4Q21 results; G9, new platforms key drivers |
【Company Research】Greentown Service (2869 HK) – Faster conversion rate is the key |
【Company Research】Excellence Commercial Property (6989 HK) – Corporate services to fuel its 35% CAGR plan; Maintain Buy |
【Company Research】China Hongqiao (1378 HK) – Attractive valuation with high dividend yield |
【Company Research】Haidilao (6862 HK) – Reforms on track but pandemic still matters |
【Company Research】Kintor Pharmaceutical (9939 HK) – Continued development of proxalutamide for COVID-19 treatment |
【Company Research】Simcere Pharmaceutical Group (2096 HK) – Expanding innovative product portfolio |
【Company Research】AK Medical (1789 HK) – High-margin customized and revision products to drive long-term growth |